Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. - Rhee JJ; Han J; Montez-Rath ME; Chertow GM (Diabetes, obesity & metabolism, 2024)